Literature DB >> 16406543

Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema.

Hideharu Funatsu1, Hidetoshi Yamashita, Shinko Nakamura, Tatsuya Mimura, Shuichiro Eguchi, Hidetaka Noma, Sadao Hori.   

Abstract

PURPOSE: To investigate whether vitreous levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) are related to diabetic macular edema (DME).
DESIGN: Retrospective case-control study. PARTICIPANTS: Thirty-six patients with DME, 6 diabetic patients without retinopathy, and 13 patients with nondiabetic ocular disease.
METHODS: After vitreous fluid samples were obtained at vitreoretinal surgery, VEGF and PEDF levels in the vitreous fluid were measured by enzyme-linked immunosorbent assay. MAIN OUTCOME MEASURES: Correlations between vascular permeability and the vitreous fluid levels of VEGF and PEDF.
RESULTS: The vitreous level of VEGF was significantly higher in patients with DME than in nondiabetic patients and diabetic patients without retinopathy (P<0.0001 and P<0.0001, respectively). Conversely, the vitreous level of PEDF was significantly lower in patients with DME than in nondiabetic patients and diabetic patients without retinopathy (P<0.0001 and P<0.0001, respectively). The vitreous level of PEDF did not correlate significantly with that of VEGF (P = 0.1806). The vitreous level of VEGF was significantly higher in patients with hyperfluorescent DME than in those with minimally fluorescent DME (P = 0.0022). Conversely, the vitreous PEDF level was significantly lower in patients with hyperfluorescent DME than in those with minimally fluorescent DME (P = 0.0172). Vitreous levels of VEGF and PEDF were related to the retinal thickness at the central fovea (P<0.0001 and P = 0.0469, respectively).
CONCLUSIONS: Our retrospective study suggests that VEGF and PEDF have an independent association with vascular permeability in the eye and on the DME, and we recommend that prospective validation of our findings be undertaken to confirm these observations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406543     DOI: 10.1016/j.ophtha.2005.10.030

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  57 in total

Review 1.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

2.  Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.

Authors:  Kyoungmin Park; Ji Jin; Yang Hu; Kevin Zhou; Jian-xing Ma
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema.

Authors:  Sachi Abe; Teiko Yamamoto; Yoshiko Kashiwagi; Eriko Kirii; Sakiko Goto; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2013-10-11       Impact factor: 2.447

4.  Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.

Authors:  Jinling Yang; Elia J Duh; Ruth B Caldwell; M Ali Behzadian
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

5.  Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus.

Authors:  M Elizabeth Hartnett; Nicholas Tinkham; Lauren Paynter; Pete Geisen; Pinchas Rosenberg; Gary Koch; Kenneth L Cohen
Journal:  Am J Ophthalmol       Date:  2009-10-17       Impact factor: 5.258

6.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

7.  Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy.

Authors:  Kocabora M Selim; Durmaz Sahan; Taskapili Muhittin; Cekic Osman; Ozsutcu Mustafa
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

8.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

Review 9.  The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

Authors:  Torsten Falk; Robert T Gonzalez; Scott J Sherman
Journal:  Int J Mol Sci       Date:  2010-08-05       Impact factor: 5.923

10.  Effect of intraocular surgery and ketamine on aqueous and serum cytokines.

Authors:  Kyaw Lin Tu; Stephen B Kaye; Gediminas Sidaras; William Taylor; Alan Shenkin
Journal:  Mol Vis       Date:  2007-07-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.